Koster A - Search Results

1

Bivalirudin anticoagulation during cardiac surgery: a single-center experience in 141 patients.

Koster A, Buz S, Krabatsch T, Yeter R, Hetzer R. Koster A, et al. Perfusion. 2009 Jan;24(1):7-11. doi: 10.1177/0267659109106109. Perfusion. 2009. PMID: 19567542

2

Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.

Koster A, Kuppe H, Hetzer R, Sodian R, Crystal GJ, Mertzlufft F. Koster A, et al. Anesthesiology. 1998 Sep;89(3):777-80. doi: 10.1097/00000542-199809000-00029. Anesthesiology. 1998. PMID: 9743416 Free article. No abstract available.

3

Recombinant hirudin for extended aortic surgery in patients with heparin-induced thrombocytopenia.

Bauer M, Koster A, Pasic M, Weng Y, Kuppe H, Hetzer R. Bauer M, et al. Among authors: koster a. J Thorac Cardiovasc Surg. 1999 Jul;118(1):191-2. doi: 10.1016/S0022-5223(99)70159-5. J Thorac Cardiovasc Surg. 1999. PMID: 10384203 Free article. No abstract available.

4

Clinical manifestation of heparin-induced thrombocytopenia type II.

Koster A, Bauer M, Pasic M, Hetzer R. Koster A, et al. Eur J Cardiothorac Surg. 1999 Jun;15(6):874-5. doi: 10.1016/s1010-7940(99)00108-6. Eur J Cardiothorac Surg. 1999. PMID: 10431876 No abstract available.

5

Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function.

Koster A, Pasic M, Bauer M, Kuppe H, Hetzer R. Koster A, et al. Ann Thorac Surg. 2000 Jan;69(1):37-41. doi: 10.1016/s0003-4975(99)01289-8. Ann Thorac Surg. 2000. PMID: 10654482

6

Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices.

Koster A, Sänger S, Hansen R, Sodian R, Mertzlufft F, Harke C, Kuppe H, Hetzer R, Loebe M. Koster A, et al. ASAIO J. 2000 May-Jun;46(3):319-22. doi: 10.1097/00002480-200005000-00015. ASAIO J. 2000. PMID: 10826744

7

A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II device.

Koster A, Loebe M, Hansen R, Bauer M, Mertzlufft F, Kuppe H, Hetzer R. Koster A, et al. J Thorac Cardiovasc Surg. 2000 Jun;119(6):1278-83. doi: 10.1067/mtc.2000.106088. J Thorac Cardiovasc Surg. 2000. PMID: 10838548 Free article.

8

Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.

Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Koster A, et al. J Cardiothorac Vasc Anesth. 2000 Jun;14(3):243-8. J Cardiothorac Vasc Anesth. 2000. PMID: 10890473

9

Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II.

Koster A, Hansen R, Grauhan O, Hausmann H, Bauer M, Hetzer R, Kuppe H, Mertzlufft F. Koster A, et al. J Cardiothorac Vasc Anesth. 2000 Jun;14(3):249-52. J Cardiothorac Vasc Anesth. 2000. PMID: 10890474

10

Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems.

Koster A, Merkle F, Hansen R, Loebe M, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F. Koster A, et al. Anesth Analg. 2000 Aug;91(2):265-9. doi: 10.1097/00000539-200008000-00003. Anesth Analg. 2000. PMID: 10910829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

910 results

Search Page

Filters